Company Update – Biogen Idec Inc. (NASDAQ:BIIB) – Who Likes Gilead, Celgene and Biogen? Nomura Does, That’s Who
January 08, 2014 at 13:47 PM EST
[at Barrons.com] – Take that Goldman Sachs. Nomura’s started covering biotech companies–and boy are its analysts feeling bullish. Of the 11 stocks it covers, eight get a Buy rating, including large-caps Gilead (GILD), . . . → Read More: Company Update – Biogen Idec Inc. (NASDAQ:BIIB) – Who Likes Gilead, Celgene and Biogen? Nomura Does, That’s Who